Genetic causes of exocrine pancreatic insufficiency (EPI) are inherited changes that stop the pancreas from making or delivering enough digestive enzymes. The best-known cause is cystic fibrosis, but rare conditions such as Shwachman-Diamond syndrome, Johanson-Blizzard syndrome, and disorders affecting pancreatic development can also be responsible. In some families, gene variants increase the risk of repeated pancreatitis, which may gradually damage the pancreas and reduce enzyme production.
How can genetic changes cause pancreatic insufficiency?
The pancreas has an important role in digestion. Its exocrine cells produce enzymes that help break down fats, proteins, and carbohydrates in food. These enzymes travel through small ducts into the small intestine, where digestion takes place.
Genetic changes can interfere with this process in several ways. Some affect the movement of fluid through pancreatic ducts, causing digestive secretions to become thick or obstructed. Others damage pancreatic cells, prevent the pancreas from developing normally, or affect the production of a specific digestive enzyme.
The result may be exocrine pancreatic insufficiency (EPI), a condition in which the pancreas cannot provide enough digestive enzymes for normal digestion. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), cystic fibrosis and rare inherited disorders are among the recognized causes of EPI, alongside acquired conditions such as pancreatitis.
Which genetic conditions are linked to exocrine pancreatic insufficiency?
Inherited EPI can occur as part of a condition affecting several organs or, much less often, as a result of a genetic defect that primarily affects pancreatic development or enzyme production. The main recognized causes include:
- Cystic fibrosis: An inherited disorder caused by changes in the CFTR gene that can damage the pancreas and impair digestive enzyme production.
- Shwachman-Diamond syndrome: A rare inherited condition associated with pancreatic dysfunction, bone marrow abnormalities, and skeletal problems.
- Johanson-Blizzard syndrome: A rare developmental disorder that can cause pancreatic insufficiency alongside other congenital abnormalities.
- Pancreatic hypoplasia or agenesis: Conditions in which the pancreas develops incompletely or is absent because of certain genetic changes.
- Inherited pancreatic enzyme deficiencies: Rare genetic defects that reduce the production or function of particular digestive enzymes.
- Hereditary or genetically influenced pancreatitis: Genetic variants can cause or increase susceptibility to repeated pancreatic inflammation, which may eventually impair digestive function.
1. Cystic fibrosis and the CFTR gene
Cystic fibrosis is the best-known inherited cause of EPI. It results from disease-causing variants in the CFTR gene, which provides instructions for making a protein that helps regulate the movement of chloride and water across cell membranes.
When the CFTR protein does not function properly, secretions in several organs can become unusually thick and sticky. In the pancreas, these secretions may obstruct ducts and damage the tissue responsible for producing digestive enzymes. As pancreatic function declines, food becomes harder to digest, particularly dietary fat.
MedlinePlus Genetics explains that CFTR variants cause cystic fibrosis by disrupting normal chloride transport and contributing to thick secretions that affect the pancreas and other organs. Cystic fibrosis is inherited in an autosomal recessive pattern, meaning that an affected person generally has disease-causing variants in both copies of the gene.
Pancreatic involvement varies among people with cystic fibrosis. Some develop pancreatic insufficiency early in life, while others retain more digestive enzyme function. The particular CFTR variants involved can help explain differences in pancreatic function, although genetic findings do not predict every aspect of an individual's health.
2. Shwachman-Diamond syndrome
Shwachman-Diamond syndrome is a rare inherited disorder that can affect the pancreas, bone marrow, and skeleton. Its pancreatic effects may begin during infancy or childhood, when insufficient digestive enzymes interfere with nutrient absorption and normal growth.
The SBDS gene is commonly associated with this syndrome. Disease-causing variants in other genes, including EFL1 and DNAJC21, can cause related forms of the condition. These genes are involved in processes important for normal cell function, including the production and maturation of ribosomes, the structures cells use to make proteins.
In affected individuals, pancreatic dysfunction may occur alongside low blood cell counts, recurrent infections related to certain blood cell deficiencies, short stature, or skeletal abnormalities. However, the combination and severity of features differ between individuals. A clinical review of Shwachman-Diamond syndrome in StatPearls, available through PubMed, describes pancreatic dysfunction and bone marrow abnormalities as central features of this disorder.
Because the condition affects more than digestion, identifying it can help clinicians recognize other health concerns that may require evaluation and ongoing monitoring.
3. Johanson-Blizzard syndrome and other rare inherited disorders
Johanson-Blizzard syndrome is a rare genetic condition associated with abnormalities in the development of several organs. It is linked to disease-causing variants in the UBR1 gene and can include pancreatic insufficiency, characteristic nasal abnormalities, dental differences, and problems affecting growth or development.
Another group of rare genetic conditions affects the development of the pancreas itself. These disorders may cause pancreatic hypoplasia, meaning the organ is smaller or less developed than usual, or pancreatic agenesis, meaning the organ is absent or fails to form properly.
Genes involved in pancreatic development include PDX1, PTF1A, and GATA6. Depending on the genetic condition, the pancreas may produce insufficient digestive enzymes and may also fail to produce enough insulin. Certain developmental disorders can therefore cause both exocrine pancreatic insufficiency and diabetes, sometimes becoming apparent during the newborn period.
A review published in Frontiers in Pediatrics on congenital causes of exocrine pancreatic insufficiency describes these syndromes and explains how inherited changes can affect pancreatic tissue, organ development, or enzyme production. These conditions are uncommon, but they are important to consider when pancreatic insufficiency begins early in life or occurs with other congenital abnormalities.
4. Rare inherited digestive enzyme deficiencies
Not every genetic cause of EPI involves widespread pancreatic damage. In rare cases, an inherited change affects the production of a particular digestive enzyme even when pancreatic tissue is present.
One example is pancreatic lipase deficiency, which can result from disease-causing variants in the PNLIP gene. Pancreatic lipase helps digest fats. When its function is markedly reduced, the body may struggle to absorb dietary fat, potentially contributing to greasy stools and nutritional problems.
Because the defect may affect one enzyme more than the others, the pattern of digestive problems can differ from that seen in conditions that damage much of the pancreas. Genetically confirmed isolated pancreatic enzyme deficiencies are exceptionally rare, and investigation generally needs to take account of the person's symptoms and test results.
5. Hereditary pancreatitis and genetic susceptibility
Some genetic changes contribute to EPI indirectly by causing or increasing the likelihood of pancreatitis. Pancreatitis is inflammation of the pancreas. When inflammation recurs or becomes chronic, it can damage pancreatic tissue and reduce the production of digestive enzymes.
Several genes have been linked to hereditary or genetically influenced pancreatitis, including:
- PRSS1: Certain disease-causing variants can lead to hereditary pancreatitis.
- SPINK1: Some variants can increase susceptibility to pancreatitis, depending on the genetic and clinical context.
- CFTR: Some variants can contribute to pancreatitis risk, including in people who do not have the typical features of cystic fibrosis.
- CTRC: Certain variants have been associated with increased susceptibility to pancreatitis.
These genes do not all have the same effect. Some variants directly cause an inherited disorder, while others act as risk factors whose effects depend on additional genetic or environmental influences. A variant associated with pancreatitis does not automatically mean that a person will develop EPI.
GeneReviews' overview of pancreatitis describes the role of hereditary disorders and genetic susceptibility in recurrent and chronic pancreatic inflammation. Genetic evaluation may be particularly relevant when pancreatitis begins at a young age, occurs repeatedly without a clear explanation, or affects several family members.
When should a genetic cause of EPI be considered?
Genetic causes are particularly relevant when pancreatic insufficiency starts in infancy or childhood, occurs alongside features of an inherited condition, or develops in a person with recurrent pancreatitis or a suggestive family history. However, a family history may be absent even when the cause is genetic, especially when a condition is inherited recessively or results from a new genetic change.
Possible features associated with EPI include:
- Loose, greasy, or unusually foul-smelling stools
- Persistent diarrhea, bloating, or excess gas
- Difficulty gaining weight or maintaining expected growth
- Signs of poor nutrient absorption or nutritional deficiencies
- Repeated episodes of pancreatitis, particularly when these begin early in life
These experiences can occur for several reasons and do not establish that a person has a genetic disorder. In children, poor growth and persistent digestive symptoms may prompt assessment for pancreatic or other digestive conditions. In adults, acquired causes such as chronic pancreatitis and pancreatic surgery are also important considerations.
How are genetic causes of pancreatic insufficiency investigated?
Evaluation usually starts with the person's symptoms, age when symptoms began, medical history, family history, and examination findings. Clinicians may assess pancreatic function using a stool elastase test and consider blood tests or other investigations to identify nutritional problems or an underlying condition.
When an inherited cause is suspected, the next steps depend on the clinical picture. Testing may focus on CFTR or on genes associated with a particular pancreatic disorder. For example, a person with features suggesting cystic fibrosis may need condition-specific testing, while someone with recurrent pancreatitis at a young age may be considered for a pancreatitis-focused genetic assessment.
Genetic testing should be selected and interpreted in the context of the person's clinical findings. A test may identify a disease-causing variant, a variant that increases risk, or a finding whose significance remains uncertain. Not every person with EPI needs genetic testing, and a genetic result alone may not confirm the cause of digestive symptoms.
When an inherited disorder is confirmed or strongly suspected, a genetic counselor or an appropriate specialist can explain how the condition is inherited and whether testing may be relevant for relatives. This can be useful when family planning or identifying an inherited condition in other family members is a concern.
Why identifying the genetic cause matters
Knowing the underlying cause can help guide care beyond the treatment of digestive enzyme deficiency. People with cystic fibrosis may need coordinated respiratory, nutritional, and pancreatic care. Those with Shwachman-Diamond syndrome may also need assessment of blood cell counts, bone marrow function, growth, and skeletal health. Individuals with a pancreatic development disorder may require evaluation for diabetes or other associated congenital conditions.
Regardless of the cause, treatment for EPI commonly includes pancreatic enzyme replacement therapy, taken with meals and snacks as directed by a healthcare professional, together with nutritional assessment and management of deficiencies when present. Treatment of the underlying genetic disorder or associated pancreatic disease is considered separately according to the specific condition.
The main distinction is that genetic changes can cause pancreatic insufficiency directly, interfere with the pancreas as it develops, or increase the risk of damage through pancreatitis. Recognizing which pathway is involved helps clinicians determine what additional assessments, family guidance, and long-term care may be appropriate.